D

Dianthus Therapeutics
D

DNTH

111.150
USD
1.60
(1.46%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-26
حجم السوق
6,217,106,115
المقالات
المزيد

العنوان: Dianthus Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.